comparemela.com

Latest Breaking News On - Stephen elledge - Page 7 : comparemela.com

Could all your digital photos be stored as DNA?

MIT biological engineers have demonstrated a way to easily retrieve data files stored as DNA. This could be a step toward using DNA archives to store enormous quantities of photos, images, and other digital content.

Gift boosts efforts to understand and combat rare cancers

Gift boosts efforts to understand and combat rare cancers Apr 9 2021 Curing cancer has been the dream of countless doctors and researchers over the decades. Yet some types of cancer, whether because they affect relatively few people or lack influential advocates, receive less attention and funding than others. Cells from a rare cancer known as blastic plasmacytoid dendritic cell neoplasm, shown in purple and blue, appear among red blood cells. Image: Clin Med Insights Case Rep 2013. doi: 10.4137/CCRep.S12608, CC-BY-NC 3.0 A recent gift to Harvard Medical School is boosting efforts to understand and combat these understudied malignancies. Established at HMS in 2019 by the Switzerland-based Bertarelli Foundation, the Bertarelli Rare Cancers Fund provides $15 million in support of research projects and community building around rare cancers.

Gift supports research into rare cancers, community-building

Gift supports research into rare cancers, community-building
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

ImmuneID Appoints Annalisa D Andrea as President and Chief Scientific Officer

Published: Apr 05, 2021     CAMBRIDGE, Mass. (BUSINESS WIRE) ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, today announced that Annalisa D’Andrea, Ph.D., has been appointed President and Chief Scientific Officer. Dr. D’Andrea brings more than 25 years of experience in translational research in immunology to ImmuneID. “The addition of Annalisa as President and CSO is an important milestone for ImmuneID, as the company applies its platform to identify promising immunological therapeutic targets,” said Stephen Elledge, Ph.D., ImmuneID co-founder and Chair of ImmuneID SAB, Lasker Award winner, and The Gregor Mendel Professor of Genetics and Medicine, Harvard Medical School. “Annalisa’s experience advancing drug candidates to the clinic will be extremely valuable and I look forward to working with her.”

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.